Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerolama Condorelli

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Molecular Therapy. Nucleic Acids|September 22, 2019
The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem CellsAlessandra Affinito, Cristina Quintavalle, Carla Lucia Esposito, et al.
Molecular Cancer|August 7, 2024
Essential gene screening identifies the bromodomain-containing protein BRPF1 as a new actionable target for endocrine therapy-resistant breast cancersAnnamaria Salvati, Giorgio Giurato, Jessica Lamberti, et al.
Oncotarget|January 23, 2016
miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRASDanilo Fiore, Elvira Donnarumma, Giuseppina Roscigno, et al.
Frontiers in Physiology|February 23, 2018
Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS ProductionGennaro Riccio, Salvatore Antonucci, Carmela Coppola, et al.
Oncotarget|November 12, 2015
MiR-221 promotes stemness of breast cancer cells by targeting DNMT3bGiuseppina Roscigno, Cristina Quintavalle, Elvira Donnarumma, et al.
Molecular Therapy. Nucleic Acids|September 12, 2022
Erratum: Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancerIolanda Scognamiglio, Lorenza Cocca, Ilaria Puoti, et al.
Molecular Therapy. Nucleic Acids|March 23, 2022
Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancerIolanda Scognamiglio, Lorenza Cocca, Ilaria Puoti, et al.
European Journal of Heart Failure|January 28, 2014
Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunctionCarlo G Tocchetti, Andrea Carpi, Carmela Coppola, et al.
Cell Death & Disease|October 27, 2017
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenibCristina Quintavalle, Sravanth Kumar Hindupur, Luca Quagliata, et al.
Cancer Cell|December 8, 2009
RETRACTED: miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulationMichela Garofalo, Gianpiero Di Leva, Giulia Romano, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Molecular Therapy. Nucleic Acids|September 22, 2019
The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem CellsAlessandra Affinito, Cristina Quintavalle, Carla Lucia Esposito, et al.
Molecular Cancer|August 7, 2024
Essential gene screening identifies the bromodomain-containing protein BRPF1 as a new actionable target for endocrine therapy-resistant breast cancersAnnamaria Salvati, Giorgio Giurato, Jessica Lamberti, et al.
Oncotarget|January 23, 2016
miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRASDanilo Fiore, Elvira Donnarumma, Giuseppina Roscigno, et al.
Frontiers in Physiology|February 23, 2018
Ranolazine Attenuates Trastuzumab-Induced Heart Dysfunction by Modulating ROS ProductionGennaro Riccio, Salvatore Antonucci, Carmela Coppola, et al.
Oncotarget|November 12, 2015
MiR-221 promotes stemness of breast cancer cells by targeting DNMT3bGiuseppina Roscigno, Cristina Quintavalle, Elvira Donnarumma, et al.
Molecular Therapy. Nucleic Acids|September 12, 2022
Erratum: Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancerIolanda Scognamiglio, Lorenza Cocca, Ilaria Puoti, et al.
Molecular Therapy. Nucleic Acids|March 23, 2022
Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancerIolanda Scognamiglio, Lorenza Cocca, Ilaria Puoti, et al.
European Journal of Heart Failure|January 28, 2014
Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunctionCarlo G Tocchetti, Andrea Carpi, Carmela Coppola, et al.
Cell Death & Disease|October 27, 2017
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenibCristina Quintavalle, Sravanth Kumar Hindupur, Luca Quagliata, et al.
Cancer Cell|December 8, 2009
RETRACTED: miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulationMichela Garofalo, Gianpiero Di Leva, Giulia Romano, et al.
Pageof 10